Qualified sourcing
Supplier, manufacturer, documentation, and production review.
For Hospitals & Health Systems
Build a coordinated patient pathway.
Pepty helps hospitals and health systems build a coordinated, verifiable peptide-care pathway: qualified sourcing with batch-level traceability, independent Philippine testing, clinician-led oversight, and digital tools for intake, monitoring, and aftercare.
The system-level case
From ad-hoc use to a documented pathway.
Peptides already circulate in the Philippine market: informally, inconsistently, often undocumented. For a health system, that is not a trend to watch; it is a liability already inside the building. Every unverified product a patient brings through your doors is a governance question without an answer.
A coordinated pathway turns that exposure into an asset: sourcing that survives an audit, testing that is independent of the supplier, handling that is recorded end to end, and clinical decisions that belong, visibly, to licensed professionals. Governance, documentation, and traceability are not overhead. They are the product.
What is documented can be defended. What is verified can be trusted.
Institutional assurance
Six gates, applied to every batch.
The Pepty Platinum Standard is the assurance layer of the pathway: a single, reviewable standard your governance committees can read, question, and rely on.
Independent testing
Product-specific testing through appropriately accredited Philippine laboratories, including DOST or UP facilities where appropriate and within scope.
Batch verification
Identity, strength, purity, sterility, endotoxins, stability, and other applicable quality attributes.
Controlled handling
Temperature monitoring, storage controls, tamper-evident packaging, and chain-of-custody records.
Clinical oversight
Licensed healthcare professionals remain responsible for evaluation, prescribing, treatment decisions, monitoring, and escalation.
Ongoing accountability
Complaint handling, adverse-event reporting, patient support, and recall procedures.
Products remain quarantined until the required documentation and testing have been reviewed. For an institution, that single rule is the difference between a program and an experiment.
Digital infrastructure
Built to integrate, ready to audit.
The pathway runs on tools designed for institutional oversight, not consumer apps with a clinical gloss.
Intake & eligibility
Structured patient intake and eligibility review, documented from first contact and routed to licensed clinicians for every decision.
Monitoring dashboards
Provider dashboards for follow-up, response tracking, andpatient care coordination across the program.
Escalation workflows
Defined paths for adverse-event reporting, complaint handling, and recall procedures, with records your institution can review at any time.
Research-adjacent honesty
Clear about what is ready, and what is not.
Tirzepatide is framed as a clinician-led program for appropriate patients, subject to prescription, product registration, medical review, and applicable Philippine requirements. It is never presented as risk-free, and eligibility is always a clinical decision.
BPC-157 and the proposed Wolverine stack are investigational. They require separate evidence, safety, regulatory, and clinical review before any patient-facing launch, and there is no patient-facing launch without that review.
No product is offered simply because demand exists.
For your medical affairs team:how testing differs from registration andquestions to ask any peptide manufacturer.
How Pepty fits
Your institution, at the center.
Your institution brings
Governance, clinical leadership, and the public trust a health system holds. The physicians who lead the program, because clinical leadership is the model, not an option.
Pepty provides
A verified supply chain with batch-level traceability. Independent Philippine testing. Digital rails for intake, monitoring, escalation, and aftercare. One reviewable standard across the entire pathway.
Questions institutions ask
How does Pepty handle documentation and traceability?
Every product carries batch-level traceability: sourcing and manufacturing documentation, independent laboratory results, chain-of-custody records, temperature and storage monitoring, and tamper-evident packaging. Products remain quarantined until the required documentation and testing have been reviewed, and the records stay available for institutional review.
Is tirzepatide available through Pepty?
Tirzepatide is framed as a clinician-led program for appropriate patients, subject to prescription, product registration, medical review, and applicable Philippine requirements. No treatment is risk-free, and eligibility is a clinical decision made by licensed healthcare professionals, never a default.
Can our clinicians lead the program?
Yes. Clinical leadership is the model, not an option. Licensed healthcare professionals remain responsible for evaluation, prescribing, treatment decisions, monitoring, and escalation. Pepty provides the verified supply chain, testing, and digital infrastructure around their judgment.